Literature DB >> 21324015

A new AMPHORA: an introduction to the project Alcohol Measures for Public Health Research Alliance.

Antoni Gual1, Peter Anderson.   

Abstract

The AMPHORA Project is a 4 years project funded by the 7th Framework Programme of the European Commission which aims to contribute with new evidence on scarcely explored or unexplored areas of alcohol consumption and alcohol-related harm in Europe. In this introductory article we describe the background of the Project and its main features. The research areas covered by AMPHORA are wide and diverse. Some of the most relevant are: an update on European epidemiological data; the definition of standard common indicators of alcohol consumption and harm; the measurement of the strength of alcohol policies; the study of contextual determinants of alcohol consumption, the analysis of the impact of marketing on youth; the availability of treatments at a European level; and two areas of harm reduction (contamination of illegal or surrogate alcohols and the reduction of harm in drinking venues).
© 2011 The Authors, Addiction © 2011 Society for the Study of Addiction.

Entities:  

Mesh:

Year:  2011        PMID: 21324015     DOI: 10.1111/j.1360-0443.2010.03349.x

Source DB:  PubMed          Journal:  Addiction        ISSN: 0965-2140            Impact factor:   6.526


  2 in total

1.  Supranational changes in drinking patterns: Factors in explanatory models of substantial and parallel social change.

Authors:  Robin Room; Thomas K Greenfield; John Holmes; Ludwig Kraus; Michael Livingston; Amy Pennay; Jukka Törrönen
Journal:  Addict Res Theory       Date:  2019-11-18

2.  A randomised controlled non-inferiority trial of primary care-based facilitated access to an alcohol reduction website (EFAR Spain): the study protocol.

Authors:  Hugo López-Pelayo; Paul Wallace; Lidia Segura; Laia Miquel; Estela Díaz; Lidia Teixidó; Begoña Baena; Pierliugio Struzzo; Jorge Palacio-Vieira; Cristina Casajuana; Joan Colom; Antoni Gual
Journal:  BMJ Open       Date:  2014-12-31       Impact factor: 2.692

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.